Efficacy Optimizing Research of Lamivudine Therapy — EXPLORE

Compensated Chronic Hepatitis B Clinical Trial

Official title:
A Prospective, Randomised, Open-label, Multi-centre Study to Compare Three Chronic Hepatitis B (CHB) Treatment Strategies Over a 2year Period in Chinese HBeAg Positive CHB Patients

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the adefovir early add-on to rescue therapy strategy, and also explore the efficacy of Lamivudine and adefovir de-novo combination therapy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01088009
Study type	Interventional
Source	Nanfang Hospital of Southern Medical University
Contact
Status	Completed
Phase	Phase 4
Start date	March 2010
Completion date	May 2013

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00877149` - Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B	Phase 4
	Withdrawn	`NCT00862706` - Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks	Phase 4